Video | TCTAP 2025
[Clinical Science] Ongoing and Future RCTs From Asan Medical Center
April 25, 2025 / 9:40 AM ~ 11:10 AM 📌 Presentation Room 1, Level 1
Moderator(s):
William F. Fearon, Gary S. Mintz
Panelist(s):
Kevin Bainey, So-Yeon Choi, James Flaherty, Alexander Goldberg, Ho Lam, Kenji Sadamatsu, Hyuck Jun Yoon
- RENOVATE Trial: DOAC vs. Warfarin for Mechanical Aortic Valve Prosthesis
Joon Bum Kim
- DEFINE-DM Trial: Imaging- and Physiology-Guided State-of-the-Art PCI vs. CABG for DM and Multi-Vessel Disease
Duk-Woo Park
- FATE-MAIN Trial: FFR- vs. Angiography-Guided Left Main PCI
Seongbong Wee
- VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
Do-Yoon Kang
- Panel Discussion l
- ASA-3C Trial: AcetylSalicylic Acid Use for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Ju Hyeon Kim
- PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI
Hansu Park
- ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR Patients
Soo Yeon An
- TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI
Hanbit Park
Panelist(s): Kevin Bainey, So-Yeon Choi, James Flaherty, Alexander Goldberg, Ho Lam, Kenji Sadamatsu, Hyuck Jun Yoon
- RENOVATE Trial: DOAC vs. Warfarin for Mechanical Aortic Valve Prosthesis
Joon Bum Kim - DEFINE-DM Trial: Imaging- and Physiology-Guided State-of-the-Art PCI vs. CABG for DM and Multi-Vessel Disease
Duk-Woo Park - FATE-MAIN Trial: FFR- vs. Angiography-Guided Left Main PCI
Seongbong Wee - VARIANT-ICD Trial: ICD vs. Medical Therapy Alone in Variant Angina With Aborted SCD
Do-Yoon Kang - Panel Discussion l
- ASA-3C Trial: AcetylSalicylic Acid Use for Primary Prevention in Severe Coronary Calcium Score on Computed Tomography
Ju Hyeon Kim - PROTECT-HBR Trial: New GI Protection Drug for High-Bleeding Risk Patients Requiring Antithrombotic Agents - P-CAB vs. PPI
Hansu Park - ENAVO-TAVR Trial: SGLT-2 Inhibitor for Post-TAVR Patients
Soo Yeon An - TAILORED-CHIP Trial: Temporal Dynamic Antiplatelet Strategy for Complex High-Risk PCI
Hanbit Park
Leave a comment